NCT00676312View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

August 31, 2008

Conditions
Postmenopausal Osteoporosis
Interventions
DRUG

PTH134

Trial Locations (1)

Unknown

Novartis Investigative site, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00676312 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects | Biotech Hunter | Biotech Hunter